Truist Financial Corp decreased its holdings in shares of Cognex Corporation (NASDAQ:CGNX – Free Report) by 69.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,660 shares of the scientific and technical instruments company’s stock after selling 60,750 shares during the quarter. Truist Financial Corp’s holdings in Cognex were worth $959,000 at the end of the most recent reporting period.
Other hedge funds have also added to or reduced their stakes in the company. Quent Capital LLC acquired a new stake in Cognex during the 3rd quarter valued at $26,000. REAP Financial Group LLC acquired a new stake in Cognex during the 3rd quarter valued at $27,000. Geneos Wealth Management Inc. lifted its holdings in Cognex by 402.2% during the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock valued at $27,000 after purchasing an additional 736 shares during the last quarter. CIBC Private Wealth Group LLC lifted its holdings in Cognex by 74.8% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock valued at $35,000 after purchasing an additional 327 shares during the last quarter. Finally, First Horizon Corp acquired a new stake in Cognex during the 3rd quarter valued at $38,000. Institutional investors and hedge funds own 88.12% of the company’s stock.
Cognex Stock Performance
CGNX opened at $64.26 on Friday. Cognex Corporation has a fifty-two week low of $29.00 and a fifty-two week high of $71.90. The company has a market capitalization of $10.69 billion, a P/E ratio of 76.50 and a beta of 1.48. The stock has a fifty day moving average of $53.97 and a 200-day moving average of $45.97.
Cognex Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, June 4th. Investors of record on Thursday, May 21st will be paid a $0.085 dividend. This represents a $0.34 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Thursday, May 21st. Cognex’s payout ratio is 40.48%.
Analyst Ratings Changes
Several brokerages have issued reports on CGNX. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $75.00 price target on shares of Cognex in a report on Thursday, May 7th. Raymond James Financial reaffirmed a “strong-buy” rating on shares of Cognex in a report on Thursday, February 12th. Needham & Company LLC raised their price target on Cognex from $67.00 to $75.00 and gave the company a “buy” rating in a report on Friday, May 8th. TD Cowen reissued a “buy” rating on shares of Cognex in a report on Tuesday, February 17th. Finally, Robert W. Baird set a $72.00 target price on Cognex in a report on Friday, May 8th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Cognex has a consensus rating of “Moderate Buy” and an average price target of $69.36.
View Our Latest Research Report on CGNX
Insider Activity at Cognex
In related news, VP Laura Ann Macdonald sold 98,122 shares of the business’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $66.80, for a total value of $6,554,549.60. Following the completion of the transaction, the vice president owned 5,258 shares of the company’s stock, valued at $351,234.40. The trade was a 94.91% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Angelos Papadimitriou sold 4,150 shares of the business’s stock in a transaction dated Monday, February 23rd. The shares were sold at an average price of $55.58, for a total value of $230,657.00. Following the completion of the transaction, the director directly owned 16,222 shares of the company’s stock, valued at approximately $901,618.76. This trade represents a 20.37% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 208,745 shares of company stock valued at $13,862,237 over the last quarter. 1.70% of the stock is owned by corporate insiders.
Key Stories Impacting Cognex
Here are the key news stories impacting Cognex this week:
- Positive Sentiment: KeyCorp raised its earnings estimates across multiple periods for Cognex, including a big increase to FY2026 EPS and a higher FY2027 forecast, while keeping an Overweight rating and $70 price target. That suggests Wall Street sees stronger profitability ahead. Article Title
- Positive Sentiment: Another Zacks item highlighted Cognex as a momentum name, reflecting improving market sentiment and technical strength around the stock. Article Title
- Positive Sentiment: Recent coverage also pointed to strong adoption of Cognex OneVision and the launch of the In-Sight 3900 embedded AI vision system, reinforcing the company’s push into AI-enabled industrial automation. Article Title
- Neutral Sentiment: Cognex also announced that CFO Dennis Fehr will present at the TD Cowen Technology, Media & Telecom Conference later this month, which is more of a visibility event than a direct catalyst. Article Title
- Negative Sentiment: A filing noted that Laura Ann Macdonald sold a large block of Cognex shares, which may weigh on sentiment slightly, though this is likely less important than the upbeat earnings and product news. Article Title
Cognex Company Profile
Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.
The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.
Featured Stories
- Five stocks we like better than Cognex
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX – Free Report).
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.
